Chinese Journal of Pharmacovigilance ›› 2017, Vol. 14 ›› Issue (1): 59-59.
• Orignal Article • Previous Articles Next Articles
Received:2017-02-16
Revised:2017-02-16
Online:2017-01-20
Published:2017-02-16
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
| [1] 陈新谦,金有豫,汤光. 新编药物学[M]. 15版,北京：人民卫生出版社,2003：61-62. [2] 卞蓉蓉,孙俊. 6916例头孢曲松钠不良反应报告分析[J]. 医学研究生学报,2012,25(6)：628-629. [3] 魏芬芳,孙怡园,杨悦.注射用头孢曲松钠不良反应的Meta分析[J].中国药物警戒, 2016, 13(6)：351-355. [4] 辛海艳,谢军燕,邱凌梅,等.关于头孢曲松钠不良反应的分析[J].世界最新医学信息文摘,2016,16(28):164. [5] 陈谦.谈谈头孢曲松钠不良反应[J].中国医药指南,2012,10(24)：65. [6] 李兆武,李亚芳,刘兴芬. 头孢曲松钠静脉滴注致低钙血症搐搦[J].药物不良反应杂志,2009,1(1)：55. [7] 李深. 头孢曲松钠导致低钙血症6例分析[J].中国医药指南,2012,10(26)：118-119. [8] 曹青文,王东明,卢琳,等.头孢曲松钠不良反应[J]. 中国误诊学杂志, 2010, 10(1)：244. [9] 李亚萍. 60例头孢曲松钠的不良反应分析[J].中国医药指南,2011, 9(36)：80. [10] 徐红冰,石卫峰,刘皋林.52例头孢曲松钠所致不良反应分析[J]. 上海医药,2015,36(1)：45. [11] 熊素英. 头孢曲松钠在临床应用中常见的不良反应及处理措施[J]. 实用心脑肺血管病杂志, 2012, 20(6)：1056. [12] 马爱华,陆晓和.头孢曲松钠的不良反应分析[J]. 抗感染学,2006, 3(3)：118. [13] 钟松阳,张慧光. 87例头孢曲松钠所致不良反应综合分析[J].中国医院药学杂志,2006, 26(11)：1447. [14] 万春燕,刘秀娟,邓剑雄,等. 2181例头孢曲松钠不良反应报告分析[J]. 广东药学院学报, 2010, 26(4)：406. [15] 袁军,董永华,张洪波. 头孢曲松钠不良反应文献研究[J]. 实用心脑肺血管病杂志, 2010, 18(11)：1605. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
